rs34261014
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_015459.5(ATL3):c.418C>T(p.Leu140Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,607,496 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 3 hom. )
Consequence
ATL3
NM_015459.5 synonymous
NM_015459.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.44
Publications
2 publications found
Genes affected
ATL3 (HGNC:24526): (atlastin GTPase 3) This gene encodes a member of a family of dynamin-like, integral membrane GTPases. The encoded protein is required for the proper formation of the network of interconnected tubules of the endoplasmic reticulum. Mutations in this gene may be associated with hereditary sensory neuropathy type IF. Alternatively spliced transcript variants that encode distinct isoforms have been described. [provided by RefSeq, Feb 2014]
ATL3 Gene-Disease associations (from GenCC):
- neuropathy, hereditary sensory, type 1FInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 11-63652563-G-A is Benign according to our data. Variant chr11-63652563-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.44 with no splicing effect.
BS2
High AC in GnomAd4 at 230 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ATL3 | ENST00000398868.8 | c.418C>T | p.Leu140Leu | synonymous_variant | Exon 4 of 13 | 1 | NM_015459.5 | ENSP00000381844.3 | ||
| ATL3 | ENST00000538786.1 | c.364C>T | p.Leu122Leu | synonymous_variant | Exon 4 of 13 | 2 | ENSP00000437593.1 | |||
| ENSG00000256789 | ENST00000540307.2 | n.553+1816G>A | intron_variant | Intron 3 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00151 AC: 230AN: 151962Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
230
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00170 AC: 420AN: 247240 AF XY: 0.00176 show subpopulations
GnomAD2 exomes
AF:
AC:
420
AN:
247240
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00191 AC: 2775AN: 1455416Hom.: 3 Cov.: 29 AF XY: 0.00185 AC XY: 1341AN XY: 724220 show subpopulations
GnomAD4 exome
AF:
AC:
2775
AN:
1455416
Hom.:
Cov.:
29
AF XY:
AC XY:
1341
AN XY:
724220
show subpopulations
African (AFR)
AF:
AC:
11
AN:
33288
American (AMR)
AF:
AC:
45
AN:
44118
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25904
East Asian (EAS)
AF:
AC:
0
AN:
39630
South Asian (SAS)
AF:
AC:
10
AN:
85202
European-Finnish (FIN)
AF:
AC:
278
AN:
53222
Middle Eastern (MID)
AF:
AC:
4
AN:
5750
European-Non Finnish (NFE)
AF:
AC:
2330
AN:
1108236
Other (OTH)
AF:
AC:
97
AN:
60066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
117
234
352
469
586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00151 AC: 230AN: 152080Hom.: 1 Cov.: 32 AF XY: 0.00135 AC XY: 100AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
230
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
100
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
20
AN:
41498
American (AMR)
AF:
AC:
11
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
AC:
38
AN:
10566
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
156
AN:
67978
Other (OTH)
AF:
AC:
4
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neuropathy, hereditary sensory, type 1F Benign:2
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ATL3: BP4, BP7 -
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.